-
Enhabit acquired by Kinderhook for $13.80 per share; goes private
Acquisition of Enhabit by Kinderhook completed at $13.80 per share; aggregate purchase price of approx. $762M.
-
Enhabit stockholders approve merger with Anchor Parent; closing expected May 15
Merger proposal approved with 36,311,910 votes for, 18,275 against, 10,917 abstained.
-
Enhabit supplements proxy disclosures amid three stockholder lawsuits challenging merger with Kinderhook
Three lawsuits filed Apr 21-28, 2026 in NY Supreme Court allege proxy omitted material info on financial projections and Goldman Sachs conflicts.
-
Enhabit sets May 12 stockholder vote for Kinderhook acquisition; HSR waiting period terminated early
Special meeting on May 12, 2026 at 8 a.m. CDT to adopt merger agreement with Anchor Parent, LLC (Kinderhook).
-
Enhabit Q4 revenue $270.4M; Adj. EBITDA $28.0M; pending $13.80/share Kinderhook merger
Net service revenue $270.4M (+4.7% YoY); adjusted EBITDA $28.0M (+11.6% YoY).
-
Enhabit enters $475M credit facility ($315M term loan A, $160M revolver) maturing 2031
$315M term loan A and $160M revolving facility, both due Feb 2031.
-
Enhabit to be acquired by Kinderhook Industries for $13.80/share, ~$1.1B EV
Cash consideration of $13.80 per share, a 24.4% premium to Feb 20 close and 33.8% to 60-day VWAP.
-
Enhabit collects $43.1M settlement in Delaware fiduciary breach case; shares VitalCaring profit stream
Collected $43.1M from former officers Walker, Schuppan, Corey for claims tied to December 2024 judgment finding egregious loyalty breaches.
-
Enhabit Q3 revenue $263.6M (+3.9% YoY), Adj. EBITDA $27.0M, raises FY guidance midpoints
Net income $11.1M vs loss of $110.2M; diluted EPS $0.22 (adj. EPS $0.17 vs $0.03).
-
Enhabit CEO Jacobsmeyer to step down by July 2026; board starts successor search
Barbara Jacobsmeyer will remain President/CEO until successor appointed or July 31, 2026.
-
Enhabit Q2 net rev $266.1M (+2.1% YoY); raises FY2025 guidance
Net service revenue $266.1M (+2.1% YoY); net income $5.2M vs loss $0.2M.
-
Enhabit Q1 net income $17.8M, adj EBITDA $26.6M; leverage ratio below 4.5x
Net service revenue $259.9M (-1% YoY); home health -5.9%, hospice +20.5%.
-
Enhabit Q4 net loss $46M on $53.8M goodwill impairment; hospice revenue up 13% YoY; issues FY2025 guidance
Net loss $46.0M (diluted EPS -$0.92) vs loss $6.4M a year ago; includes $53.8M non-cash goodwill impairment.
-
Enhabit & Encompass win lawsuit; awarded 43% of VitalCaring Group profits
Court found three former officers and Vistria/Nautic aided egregious breaches of duty of loyalty.
-
Enhabit (EHAB) appoints Ryan Solomon as CFO effective Dec 9, 2024
Ryan Solomon named CFO; succeeds Crissy Carlisle as part of planned transition.
-
Enhabit Q3 net loss $110.2M, adjusted EBITDA $24.5M, guides revenue down
Net loss $110.2M ($2.20 EPS); adjusted EPS $0.03; revenue $253.6M, down 1.8% YoY.
-
Enhabit Q2 net loss $0.2M; adj. EBITDA $25.2M; guides 2024 revenue $1.05-1.063B
Net loss $0.2M (diluted EPS $0.00); adj. EPS $0.07; adj. EBITDA $25.2M, up 5.4% YoY.
-
Enhabit CFO Crissy Carlisle to step down by Dec 31, 2024
CFO Crissy Carlisle's employment ends Dec 31, 2024 or earlier; separation agreement filed as Exhibit 10.1.
-
Enhabit prelim Q2 2024 adj. EBITDA $24.5-25.0M, reduces debt $15M, admissions up 6.4% YoY
Adjusted EBITDA guidance of $24.5M-$25.0M for Q2 2024.
-
Enhabit concludes strategic review without sale; Q1 rev $262.4M, Adj. EBITDA $25.3M
Board ends strategic alternatives review, will remain independent; no formal proposals received.
-
Enhabit Q4 net loss $6.4M, adjusted EPS $0.06; FY2024 guidance expects $98-$110M EBITDA
Q4 net service revenue $260.6M (-1% YoY); net loss $6.4M vs $95.2M loss in prior year (includes $109M goodwill impairment then).
-
Enhabit Q3 net loss $2.4M; cuts 2023 guidance; amends credit covenant to 6.75x
Q3 net service revenue $258.3M (down 2.8% YoY); adjusted EBITDA $23.2M (down 26.8%); adjusted EPS $0.03 vs $0.19.
-
Enhabit obtains covenant waiver for Q3 2023; revolver cut to $230M
Limited Waiver exempts compliance with Total Net Leverage Ratio and Interest Coverage Ratio as of Sept 30, 2023 test date.
-
Enhabit Q2 net loss $74.1M; cuts FY23 guidance; plans strategic alternatives process
Q2 net loss $74.1M ($1.49 diluted loss per share); adjusted EPS $0.04, down 91.5% YoY.
-
Enhabit amends credit agreement to raise leverage caps and restrict dividends
Maximum Total Net Leverage Ratio raised to 5.25x through Dec 2023, stepping to 4.50x by Sep 2024.
-
Enhabit Q1 revenue $265.1M, Adj EBITDA down 46% YoY; reaffirms FY guidance
Q1 net service revenue $265.1M (-3.4% YoY); net income $3.2M ($0.05 EPS), adjusted EPS $0.09 vs $0.56 prior.
-
Enhabit corrects Q4 2022 results: net loss $94.7M, revenue down 4.7% YoY
Corrected Q4 2022 net loss of $94.7M ($1.91 loss per diluted share); adjusted EPS $0.17.
-
Enhabit delays FY2022 10-K, discloses $12M AR understatement and material weakness
Company unable to file FY2022 10-K by due date; goodwill impairment analysis not finalized.
-
Enhabit appoints McGuigan and Schochet to board under cooperation agreement with activist investors
Board expanded to 13 directors; Stuart McGuigan and Barry Schochet appointed immediately.
-
Enhabit Q4 net income down 72.5% to $8.2M; guides FY23 adj EBITDA $125-140M
Net service revenue $275.1M (-0.4% YoY); adj EBITDA $40.3M (-17.8% YoY).
-
Enhabit Q3 net revenue $265.7M (-3% YoY); cuts FY 2022 guidance across all metrics
Net revenue $265.7M (-3% YoY); net income $8.6M (-60.2%); adjusted EPS $0.19 vs $0.50.
-
Enhabit completes spin-off from Encompass Health, trades as EHAB; borrows $570M, appoints two directors
Spin-off effective July 1, 2022; Encompass shareholders received 1 EHAB share per 2 Encompass shares.
-
Enhabit spin-off from Encompass cleared; distribution 1-for-2 on July 1
Registration statement on Form 10 became effective June 17, 2022.